Menu

Elite Pharmaceuticals, Inc. ELTP

Full chart Compare
Set alert

Price alert · ELTP

All alert types
0.24 USD 0.00 (+0.00%)

At closeNov 6, 2026, 4:00 PM EST

0.2321 Day range 0.241
0.21 52-week range 0.69
YTD
-51.02%
1 year
-60.00%

Revenue & Expenses

Other Income → Gross Profit & Other Income: $1.42MGross Profit & Other Income → Net Income: $3.56MGross Profit & Other Income → Selling, General & Admin: $5.12MGross Profit & Other Income → Research & Development: $6.20MGross Profit & Other Income → Other Operating Expenses: $1.60MGross Profit & Other Income → Interest Expense: $1.11MGross Profit & Other Income → Income Tax: $424.03KGross Profit → Gross Profit & Other Income: $16.59MRevenue → Gross Profit: $16.59MRevenue → Cost of Revenue: $17.56MOther Income$1.42MGross Profit$16.59MCost of Revenue$17.56MGross Profit & Other Income$18.02MNet Income$3.56MSelling, General & Admin$5.12MResearch & Development$6.20MOther Operating Expenses$1.60MInterest Expense$1.11MIncome Tax$424.03KRevenue$34.16M

Latest period ending Mar 31, 2023 · select a line to chart its full history

ELTP annual income statement
Fiscal yearFY 2023 Mar 31, 2023FY 2022 Mar 31, 2022FY 2021 Mar 31, 2021FY 2020 Mar 31, 2020FY 2019 Mar 31, 2019
34.16M32.26M25.38M17.99M7.57M
16.59M14.80M11.87M7.98M2.87M
3.68M5.07M2.10M-2.29M-9.16M
3.56M8.90M5.09M-2.24M-9.28M
ELTP annual balance sheet
Fiscal yearFY 2023 Mar 31, 2023FY 2022 Mar 31, 2022FY 2021 Mar 31, 2021FY 2020 Mar 31, 2020FY 2019 Mar 31, 2019
7.83M8.54M3.19M1.13M2.28M
40.90M35.15M26.19M24.96M24.40M
11.94M9.93M10.04M14.30M13.01M
3.89M2.78M2.38M4.03M3.98M
28.96M25.22M16.15M10.66M-2.51M
ELTP annual cash flow
Fiscal yearFY 2023 Mar 31, 2023FY 2022 Mar 31, 2022FY 2021 Mar 31, 2021FY 2020 Mar 31, 2020FY 2019 Mar 31, 2019
3.34M6.51M3.19M-1.79M-6.79M
-5.74M-498.57K-262.78K-34.95K330.87K
1.70M-667.13K-869.83K689.54K1.57M
-5.74M-498.57K-262.78K-34.95K-19.13K
-695.72K5.34M2.06M-1.14M-4.90M